CAPR
Capricor Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$30.50
-2.92 ▼ -8.74%
🌙 3월 13일 7:36 PM ET (한국 3/14 08:36)
$30.45
-0.05 ▼ -0.16%
| Index | RUT | P/E | - | EPS (ttm) | -2.26 | Insider Own | 10.24% | Shs Outstand | 0.06B | Perf Week | 9.32% |
| Market Cap | 1.66B | Forward P/E | - | EPS next Y | -352.97% | Insider Trans | - | Shs Float | 0.05B | Perf Month | 26.03% |
| Enterprise Value | 1.36B | PEG | - | EPS next Q | -0.52 | Inst Own | 56.83% | Short Float | 14.11% | Perf Quarter | 6.38% |
| Income | -0.11B | P/S | - | EPS this Y | 105.8% | Inst Trans | 33.25% | Short Ratio | 5.34 | Perf Half Y | 373.6% |
| Sales | 0.00B | P/B | 5.72 | EPS next 5Y | - | ROA | -39.91% | Short Interest | 6.89M | Perf YTD | 5.68% |
| Book/sh | 5.33 | P/C | 5.22 | EPS past 3/5Y | -24.12% -20.84% | ROE | -46.56% | 52W High | -24.45% ($40.37) | Perf Year | 138.47% |
| Cash/sh | 5.85 | P/FCF | - | Sales past 3/5Y | - | ROIC | -106.87% | 52W Low | 609.3% ($4.30) | Perf 3Y | 573.29% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -88.47% | Gross Margin | - | Volatility(W/M) | 9.68% 7.69% | Perf 5Y | 488.8% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 2.28 | Perf 10Y | 41.2% |
| Dividend Ex-Date | - | Quick Ratio | 3.59 | EPS Q/Q | -286.24% | Profit Margin | - | RSI (14) | 58.74 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.59 | Sales Q/Q | -100% | SMA20 | 8.53% ($28.1) | Beta | 0.44 | Target Price | $54.44 |
| Payout | - | Debt/Eq | 0.06 | Earnings | 3000000 | SMA50 | 17.73% ($25.91) | Rel Volume | 2.02 | Prev Close | $33.42 |
| Employees | 160 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | -21.81% -100% | SMA200 | 115.21% ($14.17) | Avg Volume(3M) | 1.29M | Price | $30.5 |
| IPO | 2002/6/20 | Option/Short | Yes/Yes | Trades | 19255 | Volume | 2,606,741 | Change | -8.74% |
뉴스 로딩 중...